What do you mean by not that great? If we continue to see improvement, isn't that better than anything else? Wouldn't any improvement over the data we already know be the best thing this world has seen (considering 5 week data was significantly better than anything this world has seen)?
Poster already tells us 12-wk data's great: dose-dependent clinical cognitive improvement observed in MMSE and other cognitive markers. Plus we already know from CTAD that at least half the ADCS-ADL data is great.
In a field where therapies aim merely to slow declines, actual cognitive improvement is great. Poster lets us know already that we have that. ADCS-ADL improvement in particular is amazing.
So it's not a matter of whether it's great. The question is how great and the answer doesn't matter all that much, though obviously the greater the better.
News 
Market Data 
Discover 
